5 Free Sessions from ESPID 2019
20 webcasts available to all!
The following ESPID 2019 sessions were live-streamed from the Meeting to support medical education and advancement in paediatric infectious diseases.
Whether you are an ESPID member or not, you can now access their recordings on the ESPID Education Portal!
PIDS/ESPID Joint Plenary Symposium
Chairs: Ulrich Heininger, Switzerland and Andi L. Shane, USA
- HPV vaccination – One dose?
Invited Speaker: Aimee Kreimer, USA
- The problems with making the right decisions
Invited Speaker: Wolfgang Gaissmaier, Germany
- Vaccine safety – How to measure it and how to communicate it
Invited Speaker: Saad Omer, USA
- Phase 3 PREPARE study: efficacy and safety of an RSV vaccine administered to pregnant women
Top Abstract: F.M. Muñoz, USA
Chair: Delane Shingadia, United Kingdom and Miroslav Petrovec, Slovenia
- Nature mortelle – The global burden of zoonotic infections
Invited Speaker: Tatjana Avšič Zupanc, Slovenia
- Pets as sources of infections
Invited Speaker: Bruno Chomel, USA
- Ticking in the woods – New insights in tick-transmitted infections in Europe
Invited Speaker: Franc Strle, Slovenia
ESWI/ESPID Joint Symposium
Chairs: Ab Osterhaus, The Netherlands and Tatjana Mrvic, Slovenia
- Childhood flu vaccination in underprivileged areas: challenges and solutions
Invited Speaker: Abdullah Brooks, USA
- Influenza B and the rationale for Quadrivalent vaccines
Invited Speaker: Ana Mosterin Höpping, UK
- Vaccine effectiveness against H3N2 influenza virus in children
Invited Speaker: Edward Belonga, USA
- Influenza and other respiratory vaccines: clinical experience with an mRNA approach
Invited Speaker: Lori Panther, USA
Chairs: Matthew Snape, United Kingdom and Tina Plankar, Slovenia
- Meningococcal protein vaccines – where next?
Invited Speaker: Shamez Ladhani, UK
- What has the South Australia Carriage Study taught us?
Invited Speaker: Helen Marshall, Australia
- Antibody persistence up to 10 years after menacwy-tt vaccine administration and immunogenicity of a booster dose in adolescents and young adults
Top Abstract: P. Peyrani, USA
Antibody persistence up to 26 months after booster dosing in adolescents 4 years following a 2- and 3-dose primary vaccination series of menb-fhbpTop Abstract: J.D. Maguire, USA
Meningococcus protein-antigen vaccines’ effects on carriage and transmission – are we asking the right questions?Top Abstract: A. Finn, United Kingdom
4cmenb, a multicomponent meningococcal vaccine developed for serogroup b meningococci elicits cross-reactive immunity also against serogroups c, w and yTop Abstract: M. Pizza, Italy
ESPID Plenary Symposium
Chairs: Johannes Trueck, Switzerland and Franc Strle, Slovenia
- New ways of doing clinical trials in infectious diseases
Invited Speaker: Diana Gibb, UK
- How do we learn what works?: Causal inference from observational studies when randomized trials are not available
Invited Speaker: Miguel A Hernan, USA
- Caesarean section is associated with increased risk of infection-related hospitalisation in childhood: a data linkage study of 7.3 million births from four countries
Top Abstract: D. Burgner, Australia
- Application of microsampling to facilitate clinical pharmacokinetic studies of antibiotics in critically ill paediatric patients
Top Abstract: S. Parker, Australia
To re-watch these sessions, please visit the dedicated page on the ESPID Education portal:
- Members: Login with your ESPID members credentials.
- Non-Members: Create a free ESPID Guest account here and use the “Guest Access” button at the top of the ESPID Education Portal to login.